When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Allogene Therapeutics (NASDAQ:ALLO): Q3 GAAP EPS of -$0.57 misses by $0.01. The Company had $861.7 million in cash, cash equivalents, and investments as of September 30, 2021. Press Release Allogene continues to expect full year GAAP Operating Expenses to be between $300 and $330 million including estimated non-cash stock-based compensation expense of $80 to $90 million and excluding any impact from potential business development activities.